Usefulness of Lipoprotein (a) for Predicting Outcomes after Percutaneous Coronary Intervention for Stable Angina Pectoris in Patients on Hemodialysis

Serum lipoprotein (a) level is genetically determined and remains consistent during a person's life. Previous studies have reported that people with high lipoprotein (a) level are at a high risk of cardiac events. We investigated the association between lipoprotein (a) levels and clinical outcomes after percutaneous coronary intervention (PCI) for stable angina pectoris (SAP) in hemodialysis (HD) patients. Serum lipoprotein (a) levels were measured on admission in 410 consecutive HD patients who underwent successful PCI for SAP.

Source: The American Journal of Cardiology - September 13, 2020 Category: Cardiology Authors: Keiichi Hishikari, Hiroyuki Hikita, Hiroshi Yoshikawa, Fumiyuki Abe, Shihoko Tsujihata, Naruhiko Ito, Yoshinori Kanno, Munehiro IIya, Tadashi Murai, Atsushi Takahashi, Taishi Yonetsu, Tetsuro Sasano Source Type: research